Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 15

1.

Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.

Cheng Z, Zhang L, Graves E, Xiong Z, Dandekar M, Chen X, Gambhir SS.

J Nucl Med. 2007 Jun;48(6):987-94. Epub 2007 May 15.

2.

64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.

Cheng Z, Xiong Z, Subbarayan M, Chen X, Gambhir SS.

Bioconjug Chem. 2007 May-Jun;18(3):765-72. Epub 2007 Mar 10.

3.

Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology.

Böhm M, Luger TA, Tobin DJ, García-Borrón JC.

J Invest Dermatol. 2006 Sep;126(9):1966-75. Review.

4.

Radiolabeled peptides in oncology: role in diagnosis and treatment.

Weiner RE, Thakur ML.

BioDrugs. 2005;19(3):145-63. Review.

PMID:
15984900
5.
6.

Cutaneous melanoma.

Thompson JF, Scolyer RA, Kefford RF.

Lancet. 2005 Feb 19-25;365(9460):687-701. Review.

PMID:
15721476
7.

Cancer statistics, 2005.

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ.

CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30. Erratum in: CA Cancer J Clin. 2005 Jul-Aug;55(4):259.

8.

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.

Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS.

Nucl Med Biol. 2004 Feb;31(2):179-89.

PMID:
15013483
9.

In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy.

Miao Y, Owen NK, Whitener D, Gallazzi F, Hoffman TJ, Quinn TP.

Int J Cancer. 2002 Oct 10;101(5):480-7.

10.

Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.

Cheng Z, Chen J, Miao Y, Owen NK, Quinn TP, Jurisson SS.

J Med Chem. 2002 Jul 4;45(14):3048-56. Erratum in: J Med Chem 2002 Sep 26;45(20):4588.

PMID:
12086490
11.

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP.

J Nucl Med. 2001 Dec;42(12):1847-55.

13.

The neuropeptide alpha-MSH in HIV infection and other disorders in humans.

Catania A, Airaghi L, Garofalo L, Cutuli M, Lipton JM.

Ann N Y Acad Sci. 1998 May 1;840:848-56. Review.

PMID:
9629310
14.

Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.

Siegrist W, Solca F, Stutz S, Giuffrè L, Carrel S, Girard J, Eberle AN.

Cancer Res. 1989 Nov 15;49(22):6352-8.

15.

Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.

Tatro JB, Wen Z, Entwistle ML, Atkins MB, Smith TJ, Reichlin S, Murphy JR.

Cancer Res. 1992 May 1;52(9):2545-8.

Supplemental Content

Support Center